Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tuberculosis sufferers will be able get drug treatment sooner thanks to a new whole genome sequencing technique to determine for the first time which drugs to give sufferers, researchers in Oxford have reported.

University of Oxford researchers at the John Radcliffe Hospital have developed a genetic test – details of which are published online today in the Lancet Infectious Diseases – that can detect which drugs will effectively treat people with the disease and those that will not.

Read more